With the acquisition of Robocath completed, Stereotaxis intends to accelerate development of next-generation robotic ...
The draft agreement outlines the Food and Drug Administration’s goals for medical device reviews from 2028 to 2032.
Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results